CVE-2026-44978 Vulnerability Analysis & Exploit Details

CVE-2026-44978
Vulnerability Scoring

5.3
/10
Significant Risk

Security assessments indicate that CVE-2026-44978 presents a notable risk, potentially requiring prompt mitigation.

Attack Complexity Details

  • Attack Complexity: Low
    Exploits can be performed without significant complexity or special conditions.
  • Attack Vector: Network
    Vulnerability is exploitable over a network without physical access.
  • Privileges Required: None
    No privileges are required for exploitation.
  • Scope: Unchanged
    Exploit remains within the originally vulnerable component.
  • User Interaction: None
    No user interaction is necessary for exploitation.

CVE-2026-44978 Details

Status: Analyzed

Last updated: 🕗 22 Jul 2026, 20:08 UTC
Originally published on: 🕔 20 Jul 2026, 17:17 UTC

Time between publication and last update: 2 days

CVSS Release: version 3

CVSS3 Source

security-advisories@github.com

CVSS3 Type

Secondary

CVSS3 Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

CVE-2026-44978 Vulnerability Summary

CVE-2026-44978: xrdp is an open source RDP server. Versions 0.10.6 and prior contain a heap out-of-bounds read vulnerability within the FIPS-specific receive paths. This vulnerability does not affect the default configuration of xrdp. The vulnerability is only exploitable when the security layer is set to security_layer=negotiate or security_layer=rdp, and the crypto level is changed to crypt_level=fips in xrdp.ini. In this specific non-default mode, the server fails to validate the FIPS padding length field, leading to a pointer underflow and a subsequent negative length calculation. An unauthenticated remote attacker can exploit this by sending a crafted FIPS-protected PDU, causing a heap out-of-bounds read that results in a process crash and denial of service (DoS). However, since xrdp forks a new process for each connection by default, an out-of-bounds read causing a process crash is unlikely to bring down the entire xrdp service. This issue has been fixed in version 0.10.6.1.

Assessing the Risk of CVE-2026-44978

Access Complexity Graph

The exploitability of CVE-2026-44978 depends on two key factors: attack complexity (the level of effort required to execute an exploit) and privileges required (the access level an attacker needs).

Exploitability Analysis for CVE-2026-44978

With low attack complexity and no required privileges, CVE-2026-44978 is an easy target for cybercriminals. Organizations should prioritize immediate mitigation measures to prevent unauthorized access and data breaches.

Understanding AC and PR

A lower complexity and fewer privilege requirements make exploitation easier. Security teams should evaluate these aspects to determine the urgency of mitigation strategies, such as patch management and access control policies.

Attack Complexity (AC) measures the difficulty in executing an exploit. A high AC means that specific conditions must be met, making an attack more challenging, while a low AC means the vulnerability can be exploited with minimal effort.

Privileges Required (PR) determine the level of system access necessary for an attack. Vulnerabilities requiring no privileges are more accessible to attackers, whereas high privilege requirements limit exploitation to authorized users with elevated access.

CVSS Score Breakdown Chart

Above is the CVSS Sub-score Breakdown for CVE-2026-44978, illustrating how Base, Impact, and Exploitability factors combine to form the overall severity rating. A higher sub-score typically indicates a more severe or easier-to-exploit vulnerability.

CIA Impact Analysis

Below is the Impact Analysis for CVE-2026-44978, showing how Confidentiality, Integrity, and Availability might be affected if the vulnerability is exploited. Higher values usually signal greater potential damage.

  • Confidentiality: None
    CVE-2026-44978 has no significant impact on data confidentiality.
  • Integrity: None
    CVE-2026-44978 poses no threat to data integrity.
  • Availability: Low
    CVE-2026-44978 may slightly degrade system performance without fully affecting service availability.

CVE-2026-44978 References

External References

CWE Common Weakness Enumeration

CWE-125

CAPEC Common Attack Pattern Enumeration and Classification

  • Overread Buffers CAPEC-540 An adversary attacks a target by providing input that causes an application to read beyond the boundary of a defined buffer. This typically occurs when a value influencing where to start or stop reading is set to reflect positions outside of the valid memory location of the buffer. This type of attack may result in exposure of sensitive information, a system crash, or arbitrary code execution.

Vulnerable Configurations

  • cpe:2.3:a:neutrinolabs:xrdp:-:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:-:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.0:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.0:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.2:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.2:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.8.0:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.8.0:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.2:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.2:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.4:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.4:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.4.:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.4.:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.5:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.5:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.6:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.6:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.7:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.7:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.8:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.8:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.9:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.9:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.10:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.10:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.11:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.11:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.12:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.12:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.13:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.13:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.13.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.13.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.14:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.14:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.15:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.15:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.16:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.16:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.17:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.17:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.18:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.18:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.18.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.18.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.19:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.19:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.20:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.20:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.21:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.21:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.21.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.21.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.22:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.22:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.22.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.22.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.23:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.23:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.23.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.23.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.24:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.24:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.25:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.25:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.25.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.25.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.26:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.26:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.27:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.27:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta2:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta2:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta3:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta3:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.2:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.2:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.2:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.2:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.3:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.3:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.4:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.4:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.4.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.4.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.5:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.5:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.6:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.6:*:*:*:*:*:*:*

Protect Your Infrastructure against CVE-2026-44978: Combat Critical CVE Threats

Stay updated with real-time CVE vulnerabilities and take action to secure your systems. Enhance your cybersecurity posture with the latest threat intelligence and mitigation techniques. Develop the skills necessary to defend against CVEs and secure critical infrastructures. Join the top cybersecurity professionals safeguarding today's infrastructures.

Other 5 Recently Published CVEs Vulnerabilities

  • CVE-2026-97663 – The Customer Reviews for WooCommerce plugin for WordPress is vulnerable to Stored Cross-Site Scripting via Comment Author Name in all versions up t...
  • CVE-2026-97641 – The Relevanssi – A Better Search plugin for WordPress is vulnerable to Stored Cross-Site Scripting via Comment Content in all versions up to, and i...
  • CVE-2026-97637 – The JSON API Auth plugin for WordPress is vulnerable to Authentication Bypass via Cached Session Cookie Disclosure in all versions up to, and inclu...
  • CVE-2026-97634 – The Event Tickets and Registration plugin for WordPress is vulnerable to generic SQL Injection via the 'orderby' parameter in all versions up to, a...
  • CVE-2026-97342 – The JetFormBuilder — Dynamic Blocks Form Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via 'choice' Post Meta via Inser...